Tech Company Financing Transactions
CancerIQ Funding Round
CancerIQ, operating out of Chicago, scored $14 million from Amgen Ventures, Merck Global Health Innovation Fund and HealthX Ventures.
Transaction Overview
Company Name
Announced On
3/4/2022
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series B
Investors
Amgen Ventures (Lead Investor)
Merck Global Health Innovation Fund (Lead Investor)
Proceeds Purpose
The company intends to use the funds to grow its precision health platform, strengthen its partnership ecosystem, and expand its health system network.
Company Information
Company Status
Private & Independent
Industry
Enterprise IT
Mailing Address
515 N State 1075
Chicago, IL 60654
USA
Chicago, IL 60654
USA
Phone
Website
Email Address
Overview
CancerIQ Risk is a suite of applications that enable the low-cost delivery of cancer risk assessment, prevention, and survivorship care. It is used by physicians and patients, and paid for by hospitals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Feyi Olopade
Chief Technical Officer
Chris Bun
Co-Founder
Olufunmilayo Olopade
VP - Product Management
Haibo Lu
Browse more venture capital transactions:
Prev: 3/4/2022: Solides Tecnologia venture capital transaction
Next: 3/4/2022: SteadyPay venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs